Kopran Limited
Kopran Limited, an integrated pharmaceutical company, engages in the development, manufacture and marketing of active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, syrups, dry powder, suspension, and injectables, as well as branded and generic formulations. It also provides d… Read more
Kopran Limited (KOPRAN) - Total Assets
Latest total assets as of September 2025: ₹8.13 Billion INR
Based on the latest financial reports, Kopran Limited (KOPRAN) holds total assets worth ₹8.13 Billion INR as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Kopran Limited - Total Assets Trend (2004–2025)
This chart illustrates how Kopran Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Kopran Limited - Asset Composition Analysis
Current Asset Composition (March 2025)
Kopran Limited's total assets of ₹8.13 Billion consist of 60.4% current assets and 39.6% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₹1.15 Million | 3.1% |
| Accounts Receivable | ₹2.23 Billion | 26.4% |
| Inventory | ₹1.69 Billion | 20.1% |
| Property, Plant & Equipment | ₹2.97 Billion | 35.2% |
| Intangible Assets | ₹255.67 Million | 3.0% |
| Goodwill | ₹58.00K | 0.0% |
Asset Composition Trend (2004–2025)
This chart illustrates how Kopran Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Kopran Limited's current assets represent 60.4% of total assets in 2025, an increase from 40.5% in 2004.
- Cash Position: Cash and equivalents constituted 3.1% of total assets in 2025, up from 0.2% in 2004.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, an increase from 2.0% in 2004.
- Asset Diversification: The largest asset category is property, plant & equipment at 35.2% of total assets.
Kopran Limited Competitors by Total Assets
Key competitors of Kopran Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Novartis AG
PINK:NVSEF
|
USA | $115.49 Billion |
|
Pfizer Inc
NYSE:PFE
|
USA | $208.73 Billion |
|
AbbVie Inc
NYSE:ABBV
|
USA | $133.96 Billion |
|
Biogen Inc
NASDAQ:BIIB
|
USA | $29.44 Billion |
|
Zhejiang Int'L Group Co Ltd
SHE:000411
|
China | CN¥17.31 Billion |
|
Zhejiang Zhenyuan Share Co Ltd
SHE:000705
|
China | CN¥3.03 Billion |
|
Hunan Jingfeng Pharmaceutical
SHE:000908
|
China | CN¥877.99 Million |
|
Hubei Guangji Pharmaceutical Co Ltd
SHE:000952
|
China | CN¥2.58 Billion |
Kopran Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Kopran Limited generates 0.75x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Kopran Limited generates $ 4.57 in net profit.
Kopran Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.63 | 2.02 | 1.75 |
| Quick Ratio | 0.99 | 1.27 | 1.09 |
| Cash Ratio | 0.14 | 0.04 | 0.00 |
| Working Capital | ₹1.72 Billion | ₹ 2.19 Billion | ₹ 1.06 Billion |
Kopran Limited - Advanced Valuation Insights
This section examines the relationship between Kopran Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.29 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 13.6% |
| Total Assets | ₹8.44 Billion |
| Market Capitalization | $34.19 Million USD |
Valuation Analysis
Below Book Valuation: The market values Kopran Limited's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Kopran Limited's assets grew by 13.6% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Kopran Limited (2004–2025)
The table below shows the annual total assets of Kopran Limited from 2004 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | ₹8.44 Billion | +13.56% |
| 2024-03-31 | ₹7.43 Billion | +14.40% |
| 2023-03-31 | ₹6.50 Billion | +6.35% |
| 2022-03-31 | ₹6.11 Billion | +39.03% |
| 2021-03-31 | ₹4.39 Billion | +18.29% |
| 2020-03-31 | ₹3.71 Billion | +5.43% |
| 2019-03-31 | ₹3.52 Billion | +11.69% |
| 2018-03-31 | ₹3.15 Billion | +5.60% |
| 2017-03-31 | ₹2.99 Billion | +13.24% |
| 2016-03-31 | ₹2.64 Billion | -4.09% |
| 2015-03-31 | ₹2.75 Billion | -8.02% |
| 2014-03-31 | ₹2.99 Billion | +13.57% |
| 2013-03-31 | ₹2.63 Billion | +5.13% |
| 2012-03-31 | ₹2.50 Billion | +7.86% |
| 2011-03-31 | ₹2.32 Billion | -0.95% |
| 2010-03-31 | ₹2.34 Billion | -0.62% |
| 2009-03-31 | ₹2.36 Billion | -12.42% |
| 2008-03-31 | ₹2.69 Billion | -27.46% |
| 2007-03-31 | ₹3.71 Billion | -14.40% |
| 2006-03-31 | ₹4.34 Billion | +2.52% |
| 2005-03-31 | ₹4.23 Billion | -11.22% |
| 2004-03-31 | ₹4.77 Billion | -- |